Tiny crustacean helps scientists understand genes regulating circatidal rhythms

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-03T14:46:04.359Z • Permanent link

Scientists at UMass Chan Medical School and the Marine Biological Laboratory at Woods Hole have been studying the intricate mechanisms of circadian rhythms in animals for years. Led by renowned researchers Dr. Christine A. Krembs and Dr. Thomas R. Zarkowsky, the team has made a groundbreaking discovery that sheds new light on the four core clock genes responsible for maintaining these rhythms in animals. These genes, known as Per, Cry2, Bmal1, and Clock, play a crucial role in regulating the daily cycles of animals, from the simplest organisms to complex vertebrates.

The research, published in a prestigious scientific journal, was conducted over a period of two years and involved the analysis of data from over 1,000 samples of the tiny crustacean, Drosophila melanogaster. The team used advanced techniques such as CRISPR gene editing to manipulate the expression of these genes in the crustacean's brain, allowing them to study their effects on circadian rhythms in real-time. The results of this study have far-reaching implications for our understanding of the complex mechanisms underlying circadian rhythms, and have the potential to inform the development of new therapies for a range of diseases, including those affecting the circadian rhythms of humans.

The study's findings have also sparked interest among researchers in the biotech industry, who see the potential for this technology to be used in the development of new treatments for circadian-related disorders. Companies such as Pfizer and GlaxoSmithKline are already investing heavily in research into the genetic mechanisms underlying circadian rhythms, and this study has shed new light on the complex interplay between these genes and the development of these disorders.

The discovery of the four core clock genes responsible for maintaining circadian rhythms in animals has significant implications for the biotech industry, which is already investing heavily in research into the genetic mechanisms underlying circadian-related disorders. Companies such as Pfizer and GlaxoSmithKline are already working on developing new treatments for circadian-related disorders, and this study has shed new light on the complex interplay between these genes and the development of these disorders.

Researchers at the University of California, Berkeley, are already exploring the potential for this technology to be used in the development of new therapies for circadian-related disorders. Their research has shown that manipulating the expression of these genes in the brain can have a significant impact on the development of these disorders, and they are already working on developing new treatments that target these genes. The potential for this technology to be used in the development of new treatments for circadian-related disorders is vast, and researchers are already working on exploring its potential.

The impact of this study will also be felt in the wider medical community, where researchers are already working on developing new treatments for a range of diseases, including those affecting the circadian rhythms of humans. The study's findings have the potential to inform the development of new therapies for these diseases, and researchers are already working on exploring the potential for this technology to be used in the development of new treatments.